| Literature DB >> 35633866 |
Natalia Saltybaeva1, Stephanie Tanadini-Lang1, Diem Vuong1, Simon Burgermeister1, Michael Mayinger1, Andrea Bink2, Nicolaus Andratschke1, Matthias Guckenberger1, Marta Bogowicz1.
Abstract
Background and purpose: Radiomics offers great potential in improving diagnosis and treatment for patients with glioblastoma multiforme. However, in order to implement radiomics in clinical routine, the features used for prognostic modelling need to be stable. This comprises significant challenge in multi-center studies. The aim of this study was to evaluate the impact of different image normalization methods on MRI features robustness in multi-center study.Entities:
Keywords: Features stability; Glioblastoma multiforme; Image normalization; Prognostic modelling; Radiomics
Year: 2022 PMID: 35633866 PMCID: PMC9130546 DOI: 10.1016/j.phro.2022.05.006
Source DB: PubMed Journal: Phys Imaging Radiat Oncol ISSN: 2405-6316
Technical characteristics and imaging protocol details for internal and external patient cohorts.
| Robustness study | Prognostic study | |||
|---|---|---|---|---|
| Characteristics | Internal cohort | External cohort | Overall survival cohort | |
| MRI scanner | ||||
| Skyra | N = 10 (91%) | N = 1 (9%) | ||
| Aera | N = 1 (9%) | |||
| Avanto | N = 1 (9%) | N = 3 (5%) | ||
| Verio | N = 4 (7%) | |||
| TrioTim | N = 1 (1%) | |||
| Symphony | N = 2 (3%) | |||
| Signa | N = 1 (9%) | |||
| Genesis Sigma | N = 1 (9%) | N = 15 (25%) | ||
| Signa Excite | N = 8 (13%) | |||
| Ingenia | N = 3 (27%) | |||
| Achieva | N = 4 (36%) | N = 5 (8%) | ||
| Intera | N = 2 (3%) | |||
| N = 20 (33%) | ||||
| Magnetic field strength | 1.16 T | |||
| 1.5 T | N = 4 (36%) | N = 33 (55%) | ||
| 3 T | N = 11 (100%) | N = 7 (64%) | N = 22 (37%) | |
| unknown | N = 5 (8%) | |||
| Slice thickness | Median (range) | 0.88 (0.7–0.9) mm | 1.17 (0.6–3.0) mm | 5.0 (1.0 – 12.5) mm |
| Repetition time (TR) | Median (range), s | 1622 (8.9–1900) s | 441.9 (5.5–2300) s | 586.3 (34.0 – 3285.6) s |
| Echo time (TR) | Median (range) | 2.65 (2.54–3.42) s | 3.78 (2.31–9) s | 8.00 (2.48 – 17.00) s |
| Flip angle | Median (range) | 9.54 (9–15) | 15.6 (8–90) | 9–90) |
Short description of the image normalization approaches considered in this study.
| Normalization | Bins | ROIs for intensity interpolation |
|---|---|---|
| Fixed bin number (FBN) | Number of bins equal to 32 | no |
| Fixed bin size (FBS1) | Bin size 30 | vitreous body of an eye, white matter |
| Fixed bin size (FBS2) | Bin size 30 | vitreous body of an eye, contrast-enhanced confluence of sinuses |
| Histogram matching (HM) | Fixed bin size of 20 | delineated VOI |
| Fixed bin size of 20,000 | brain mask | |
| Z-score (ZS) | Fixed bin size of 0.15 | delineated VOI |
| Fixed bin size of 0.2 | brain mask |
The patient characteristics and the time gap between two MR acquisitions for each patient.
| Patient | Gender | MGMT mutation status | IDH mutation status | Age, years | Time between scans, days |
|---|---|---|---|---|---|
| 1 | male | positive | not confirmed | 72 | 5 |
| 2 | female | not confirmed | not confirmed | 60 | 2 |
| 3 | male | not confirmed | positive | 52 | 8 |
| 4 | female | negative | negative | 70 | 6 |
| 5 | male | negative | negative | 76 | 36 |
| 6 | male | negative | negative | 72 | 9 |
| 7 | male | not confirmed | negative | 69 | 4 |
| 8 | male | positive | positive | 30 | 1 |
| 9 | female | negative | not confirmed | 75 | 17 |
| 10 | female | negative | negative | 66 | 9 |
| 11 | male | negative | negative | 86 | 11 |
Number of robust features using different normalization approaches.
| Normalization | Stable features, ICC > 0.9 | ||||
|---|---|---|---|---|---|
| Shape | Intensity | Texture | Wavelets | All | |
| FBN | 16/18 | 0/17 | 4/137 | 63/1232 | 83/1404 ( |
| FBS1 | 16/18 | 0/17 | 9/137 | 23/1232 | 48/1404 ( |
| FBS2 | 16/18 | 0/17 | 7/137 | 32/1232 | 55/1404 ( |
| HM_VOI | 16/18 | 3/17 | 22/137 | 72/1232 | 113/1404 ( |
| HM_brain | 16/18 | 2/17 | 13/137 | 74/1232 | 104/1404 ( |
| ZS_VOI | 16/18 | 1/17 | 13/137 | 53/1232 | 83/1404 ( |
| ZS_brain | 16/18 | 0/17 | 12/137 | 49/1232 | 77/1404 ( |
| Regardless of the normalization | 16/18 | 0/17 | 2/137 | 8/1232 | 26/1404 ( |
Fig. 1The percentages of stable features by categories for FBN, FBS1, FBS2, HM_VOI, HM_brain, ZS_VOI and ZS_brain normalizations.
Correlations between features and tumor volume.
| Normalization | Highly correlated features, |r| >0.8 | Strongly correlated features, |r| >0.6 | Weakly correlated features, |r| <0.6 |
|---|---|---|---|
| FBN | 8/83 | 67/83 | 9/83 |
| FBS1 | 37/48 | 8/48 | 3/48 |
| FBS2 | 40/55 | 7/55 | 8/55 |
| HM_VOI | 57/113 | 19/113 | 37/113 |
| HM_brain | 54/104 | 11/104 | 39/104 |
| ZS_VOI | 59/83 | 11/83 | 13/83 |
| ZS_brain | 53/77 | 12/77 | 12/77 |